Search Results - "Saenen, J"

Refine Results
  1. 1
  2. 2

    Long-term effect of atrial fibrillation on the evolution of mitral and tricuspid valve regurgitation by Pype, L., Embrechts, L., Cornez, B., Van Paesschen, C., Sarkozy, A., Miljoen, H., Heuten, H., Saenen, J., Van Herck, P., de Heyning, C. M. Van, Heidbuchel, H., Claeys, M. J.

    Published in Acta Cardiologica (14-10-2020)
    “…Objective: The present study aims to identify the long-term effects of atrial fibrillation (AF) on atrial remodelling and on the progression of…”
    Get full text
    Journal Article
  3. 3

    Genetics of sudden cardiac death in the young by Saenen, J.B., Van Craenenbroeck, E.M., Proost, D., Marchau, F., Van Laer, L., Vrints, C.J., Loeys, B.L.

    Published in Clinical genetics (01-08-2015)
    “…Sudden cardiac death (SCD) has an enormous impact on those who are left behind, evoking strong feelings of anxiety and incomprehension because such a dramatic…”
    Get full text
    Journal Article
  4. 4

    Molecular aspects of the congenital and acquired Long QT Syndrome: Clinical implications by Saenen, J.B, Vrints, C.J

    “…Abstract The Long QT Syndrome (LQTS) is a complex and multi-factorial disorder that predisposes to life-threatening ventricular arrhythmias. Both hereditary…”
    Get full text
    Journal Article
  5. 5

    Modulation of HERG Gating by a Charge Cluster in the N-Terminal Proximal Domain by Saenen, J.B., Labro, A.J., Raes, A., Snyders, D.J.

    Published in Biophysical journal (15-12-2006)
    “…Human ether-a-go-go-related gene (HERG) potassium channels contribute to the repolarization of the cardiac action potential and display unique gating…”
    Get full text
    Journal Article
  6. 6

    A single hERG mutation underlying a spectrum of acquired and congenital long QT syndrome phenotypes by Saenen, J.B, Paulussen, A.D.C, Jongbloed, R.J, Marcelis, C.L, Gilissen, R.A.H.J, Aerssens, J, Snyders, D.J, Raes, A.L

    “…Abstract The long QT syndrome (LQTS) is a multi-factorial disorder that predisposes to life-threatening arrhythmias. Both hereditary and acquired subforms have…”
    Get full text
    Journal Article
  7. 7

    Implantable loop recorders in children and adolescents with Brugada syndrome: the YoungBruLoop study by Conte, G, Ciconte, G, Bergonti, M, Crotti, L, Tondo, C, Rossi, A, De Asmundis, C, Caputo, M L, Casella, M, Saenen, J, Pappone, C, Schwartz, P, Auricchio, A, Brugada, P, Sarquella Brugada, G

    Published in European heart journal (28-10-2024)
    “…Abstract Background Young (<18 years of age) patients with Brugada syndrome (BrS) are often underrepresented in BrS studies and their management, especially…”
    Get full text
    Journal Article
  8. 8

    High density mapping accuracy and efficiency in atrial fibrillation: real-world outcomes from the SECURE registry by Di Monaco, A, Gallagher, M M, Purerfellner, H, Saenen, J, Chun, J, Deisenhofer, I, Duytschaever, M, Ng, G A, Rosso, R, De Potter, T, Ahsan, S, Chierchia, G B, Grimaldi, M, Vijgen, J

    Published in European heart journal (28-10-2024)
    “…Abstract Background/Introduction A high-density (HD) mapping catheter is valuable for validating pulmonary vein isolation (PVI) and analysing arrhythmic…”
    Get full text
    Journal Article
  9. 9

    Progression and regression in the left atrial substrate in patients with atrial fibrillation: the PROGRESS-AF study by Marcon, L, Bergonti, M, Van Leuven, O, Spera, F R, Saenen, J, Huybrechts, W, Miljoen, H, Heidbuchel, H, Sarkozy, A

    Published in Europace (London, England) (24-05-2023)
    “…Abstract Funding Acknowledgements Type of funding sources: None. Background Progression or regression of the atrial substrate in atrial fibrillation (AF) has…”
    Get full text
    Journal Article
  10. 10

    Modeling of an SCN5A founder mutation in iPSC-derived cardiomyocytes by Simons, E, Nijak, A, Vandendriessche, B, Van De Sande, D, Sieliwonczyk, E, Labro, A J, Saenen, J, Snyders, D, Schepers, D, Loeys, B, Alaerts, M

    Published in Cardiovascular research (10-06-2022)
    “…Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Research Foundation - Flanders (FWO)…”
    Get full text
    Journal Article
  11. 11

    Anterior mitral line in patients with persistent AF and anterior scar: a multicenter matched comparison. The MiLine Study by Bergonti, M, Spera, F R, Gonzalez Ferrero, T, Nsahlai, M, Saenen, J, Huybrechts, W, Miljoen, H, Heidbuchel, H, Valderrabano, M, Rodriguez Manero, M, Sarkozy, A

    Published in Europace (London, England) (24-05-2023)
    “…Abstract Funding Acknowledgements Type of funding sources: None. Background The benefit of an anterior mitral line (AML) in patients with persistent atrial…”
    Get full text
    Journal Article
  12. 12

    Post-shock acute electrical parameters of left bundle branch area defibrillation (LBBAD) leads by Huybrechts, W, Bergonti, M, Saenen, J, Miljoen, H, Van Assche, L, Van Leuven, O, De Cleen, D, Sarkozy, A, Van Herck, P, Heidbuchel, H

    Published in Europace (London, England) (24-05-2023)
    “…Abstract Funding Acknowledgements Type of funding sources: None. Background Conduction system pacing is a growing field in bradycardia-treatment. Evidence for…”
    Get full text
    Journal Article
  13. 13

    An emerging role for DPP6: reciprocal regulation of INa-Ito and implications for arrhythmogenesis by Rossetti, A, Spatjens, R L H, Kammerer, S, Stoks, J, Firneburg, R, Seyen, S R, Helderman-Van Den Enden, A T J M, Wilde, A A M, Loeys, B L, Saenen, J, Heijman, J, Volders, P G A

    Published in European heart journal (03-10-2022)
    “…Abstract Background Since the association of a chromosomal risk haplotype harboring dipeptidyl peptidase-like protein-6 (DPP6) to familial idiopathic…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Microelectrode voltage mapping for substrate assessment in catheter ablation of ventricular tachycardia: a dual-center experience by Compagnucci, P, Dello Russo, A, Bergonti, M, Cipolletta, L, Parisi, Q, Volpato, G, Colonnelli, M, Saenen, J, Valeri, Y, Carboni, L, Marchese, P, Marini, M, Sarkozy, A, Natale, A, Casella, M

    Published in Europace (London, England) (24-05-2023)
    “…Abstract Funding Acknowledgements Type of funding sources: None. Background The assessment of the ventricular myocardial substrate critically depends on the…”
    Get full text
    Journal Article
  16. 16

    Implantable Loop Recorders in patients with Brugada Syndrome: the BruLoop Study by Bergonti, M, Sacher, F S, Arbelo, E A, Crott, L, Sabbag, A S, Casella, M C, Saenen, J S, Sfondrini, I S, De Asmundis, C D A, Brugada, J B, Tondo, C T, Schwarz, P S, Haissaguerre, M G, Auricchio, A A, Conte, G C

    Published in Europace (London, England) (24-05-2024)
    “…Abstract Aims Available data on continuous rhythm monitoring by implantable loop recorders (ILRs) in patients with Brugada syndrome (BrS) are scarce. Aim of…”
    Get full text
    Journal Article
  17. 17

    P1878Long-term effect of atrial fibrillation on the evolution of mitral and tricuspid valve regurgitation by Pype, L, Embrechts, L, Cornez, B, Van Paesschen, C, Sarkozy, A, Miljoen, H, Heuten, H, Saenen, J, Van Herck, P, Van De Heyning, C, Heidbuchel, H, Claeys, M

    Published in European heart journal (01-10-2019)
    “…Abstract Background While severe mitral regurgitation is a well-established risk factor for atrial fibrillation (AF), it is less known whether atrial…”
    Get full text
    Journal Article
  18. 18

    P435Reproducibility and predictive value of a simple novel method to measure pulmonary vein activity in persistent atrial fibrillation FARS AF CL study by Spera, F, Rodriguez-Manero, M, Baluja, A, Mortelmans, P, Saenen, J, Miljoen, H, Huybrechts, W, Bories, W, Vandaele, L, Ennekens, G, Heidbuchel, H, Sarkozy, A

    Published in Europace (London, England) (01-06-2020)
    “…Abstract Funding Acknowledgements No disclosure Introduction. Pulmonary vein (PV) firing can trigger or act as a rapid driver to maintain atrial fibrillation…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Mitral regurgitation attenuates thrombotic risk in nonrheumatic atrial fibrillation: a new CHA2DS2-VASc score risk modifier? by Van Laer, SL, Winkler, KM, Verreyen, S, Miljoen, H, Sarkozy, A, Heuten, H, Saenen, J, Van Herck, P, Van De Heyning, CM, Heidbuchel, H, Claeys, MJ

    Published in Europace (London, England) (24-05-2021)
    “…Abstract Funding Acknowledgements Type of funding sources: None. Background/Introduction: Atrial fibrillation (AF) carries a thrombotic risk related to left…”
    Get full text
    Journal Article